In 2024, the United States leads the global digital health ecosystem, driven by a robust landscape of ventures, investors, and partnerships that are shaping the future of healthcare. With the largest number of digital health startups worldwide and the highest venture survival rates, the U.S. continues to be a key player in advancing healthcare technology. Leveraging proprietary data from Galen Growth’s HealthTech Alpha platform, the analysis covers critical aspects such as venture survival rates, clinical evidence, and the role of partnerships in driving innovation and growth.
This overview captures the U.S. digital health sector’s resilience and innovation, underscored by strong investment flows, a focus on disease-specific solutions, and robust partnership ecosystems.
Also read our China Digital Health Key Trends 2024.
Our Premium Reports are specialized reports that are only available to active users with HealthTech Alpha Pro and HealthTech Alpha Enterprise accounts and are provided at no additional cost.
Galen Growth’s proprietary platform, HealthTech Alpha, provides the data source for this report. Corporate Business Development, Business Intelligence, and Digital Health Partnership teams worldwide prefer HealthTech Alpha, the world’s most-trusted Digital Health data, intel, and insights platform. Visit https://www.healthtechalpha.com to learn more about our data or https://www.galengrowth.com research for our reports.
Founded in 2016 by Digital Health experts, Galen Growth empowers global Fortune 500 companies, institutional investors, and promising Digital Health ventures to fast track their digital health strategy to create significant financial and social values. To find out more, visit https://www.galengrowth.com
Key Findings | |
Digital Health ventures in the US | |
Digital Health funding in the US | |
Medical specialties of Digital Health ventures in the US | |
Notable ventures | |
Notable investors |